Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical outcomes following transcatheter aortic valve replacement in patients with concordant versus discordant aortic stenosis.

American heart journal plus : cardiology research and practice·2026
Same author

New 2030 Global Targets for Histoplasmosis from International Society for Human and Animal Mycology (ISHAM) 2025 Histoplasmosis Working Group.

Emerging infectious diseases·2026
Same author

Trabecular bone score enhances fracture risk stratification in patients with metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitus.

Journal of endocrinological investigation·2026
Same author

Flow Gradients in Severe Aortic Stenosis and Preserved Ejection Fraction: A 10-Year Transcatheter Aortic Valve Replacement Study.

Journal of the Society for Cardiovascular Angiography & Interventions·2026
Same author

Retraction Note: Farnesyl dimethyl chromanol targets colon cancer stem cells and prevents colorectal cancer metastasis.

Scientific reports·2025
Same author

Statins Do Not Affect Bone Anabolism in Older Women Treated With Teriparatide.

The Journal of clinical endocrinology and metabolism·2025

Related Experiment Video

Updated: Jun 30, 2026

Isolation, Culture, and Characterization of Prostate Cancer-Associated Fibroblasts
09:43

Isolation, Culture, and Characterization of Prostate Cancer-Associated Fibroblasts

Published on: August 1, 2025

Bax-interacting factor-1 expression in prostate cancer.

Domenico Coppola1, Cecilia Oliveri, Zena Sayegh

  • 1Department of Anatomic Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612-9497, USA. coppold@moffitt.usf.edu

Clinical Genitourinary Cancer
|October 1, 2008
PubMed
Summary
This summary is machine-generated.

Bax-interacting factor (Bif)-1 protein, involved in apoptosis, showed varied expression in prostate cancer. Loss of Bif-1 was observed in some cancers, while increased levels were found in high-grade prostatic intraepithelial neoplasia (PIN).

More Related Videos

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal
08:00

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal

Published on: October 11, 2019

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

Related Experiment Videos

Last Updated: Jun 30, 2026

Isolation, Culture, and Characterization of Prostate Cancer-Associated Fibroblasts
09:43

Isolation, Culture, and Characterization of Prostate Cancer-Associated Fibroblasts

Published on: August 1, 2025

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal
08:00

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal

Published on: October 11, 2019

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Bax-interacting factor (Bif)-1 is a proapoptotic protein crucial for regulating cell death.
  • Loss of Bif-1 function is linked to suppressed apoptosis and tumor development.
  • Prostate cancer progression involves complex molecular alterations, including changes in apoptotic regulators.

Purpose of the Study:

  • To investigate the expression levels of Bif-1 protein in human prostate cancer tissues.
  • To correlate Bif-1 expression with different stages of prostate pathology, including normal, benign prostatic hyperplasia (BPH), prostatic intraepithelial neoplasia (PIN), and prostate cancer.
  • To explore the potential of Bif-1 as a therapeutic target in prostate cancer.

Main Methods:

  • Immunohistochemical staining was performed on archival prostate cancer tissue specimens and a tissue microarray.
  • The study included normal prostate tissue, BPH, PIN, and prostate cancer samples.
  • Bif-1 antibody was used, and slides were scored by two independent observers.

Main Results:

  • Moderate to strong Bif-1 staining was detected in most non-microarray prostate cancer samples (38/39).
  • High-grade PIN adjacent to cancer showed strong and diffuse Bif-1 staining (90.6%).
  • BPH samples exhibited weak Bif-1 positivity (88.9%), while normal prostate tissue showed low to moderate Bif-1 expression.

Conclusions:

  • Bif-1 expression loss in a subset of prostate cancers aligns with its proapoptotic role.
  • Elevated Bif-1 in some prostate cancers and PIN warrants further investigation.
  • Bif-1's role in prostate cancer suggests its potential as a therapeutic target.